Longevity Biomarkers to Track in 2026: The Complete Guide

Photo by Prasesh Shiwakoti (Lomash) on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated July 2026

The longevity biomarkers to track in 2026 have expanded well beyond a basic cholesterol panel. Researchers can now measure how fast your cells are aging, how well your heart and muscles are functioning, and even read molecular signals in your blood that predict disease risk years before symptoms appear. This guide covers every major biomarker category, what the science says about each one, and how to use the data — not just collect it.

Why Biomarker Tracking Matters More in 2026

Waiting for symptoms is the old model of medicine. By the time most age-related diseases produce symptoms, decades of silent damage have already occurred. Cardiovascular disease, metabolic dysfunction, and cognitive decline all have long, measurable preclinical phases — and biomarkers are the only way to see inside them.

Dr. Peter Attia calls this “Medicine 3.0” in his book Outlive: a proactive framework built around measuring, acting, and measuring again. The goal isn’t to treat disease after it arrives. The goal is to prevent it from arriving at all. Biomarkers are the scoreboard for that project.

At the same time, not every biomarker earns its hype. Some are validated across decades of human research. Others are promising signals that have only been tested in small cohorts or animal models. This guide tells you which is which — directly.

The Core Metabolic Biomarkers Every Adult Should Track

Metabolic dysfunction is the upstream driver of most chronic diseases that shorten life. These markers are affordable, widely available, and deeply meaningful when read together.

Fasting Glucose and Fasting Insulin

Fasting glucose alone misses the full picture. Fasting insulin tells you how hard your pancreas is working to keep glucose normal. High fasting insulin (above 8-10 uIU/mL) with normal glucose is the classic signature of early insulin resistance — a state that can persist silently for 10-15 years before type 2 diabetes appears. The HOMA-IR calculation (fasting glucose x fasting insulin, divided by 405) gives you a single number for insulin sensitivity. A HOMA-IR below 1.0 is optimal; above 2.0 suggests meaningful resistance.

HbA1c (Glycated Hemoglobin)

HbA1c reflects your average blood sugar over the previous 90 days. It’s a better integrator of metabolic health than a single fasting glucose reading. Most longevity-focused clinicians target HbA1c below 5.4% — the standard “normal” cutoff of 5.7% still carries elevated risk compared to optimal. Research from the NIH National Institute on Aging consistently shows that even mildly elevated HbA1c in midlife predicts accelerated cognitive decline.

Triglycerides and HDL

The triglyceride-to-HDL ratio is a strong proxy for insulin resistance and cardiovascular risk. A ratio below 1.5 (in mg/dL units) is associated with favorable cardiometabolic outcomes. Above 3.0 suggests significant metabolic stress. This single ratio costs nothing extra to calculate from a standard lipid panel.

ApoB (Apolipoprotein B)

ApoB is the most important cardiovascular biomarker most doctors still don’t order. Each LDL particle carries one ApoB protein, so ApoB directly counts the number of atherogenic particles in your blood — something LDL-cholesterol can’t do accurately. Dr. Attia and cardiologist Dr. Tom Dayspring both cite ApoB as the primary target for cardiovascular risk reduction. Optimal ApoB for longevity-focused adults is generally considered below 80 mg/dL; many longevity clinicians target below 60 mg/dL for higher-risk individuals.

Cardiovascular and Functional Fitness Biomarkers

These markers don’t come from a blood draw. But evidence shows they may be the most powerful predictors of how long you actually live.

VO2 Max

VO2 max — your maximum rate of oxygen consumption during exercise — is the most validated longevity biomarker in human research. A landmark 2018 study published in JAMA Network Open, analyzing 122,007 patients at the Cleveland Clinic, found that moving from the lowest fitness quartile to just above it was associated with a 45% reduction in all-cause mortality. No drug, supplement, or intervention in longevity research has produced a comparable effect size in humans.

For context on what good looks like: a 50-year-old man with a VO2 max above 48 mL/kg/min sits in the “superior” category. Most sedentary adults in that age group sit in the 30s. Our full guide on VO2 max as a longevity predictor covers how to test and improve it.

Resting Heart Rate and Heart Rate Variability (HRV)

Resting heart rate below 60 bpm is associated with significantly lower cardiovascular mortality risk. Heart rate variability (HRV) — the variation in time between heartbeats — reflects autonomic nervous system health and recovery capacity. Higher HRV generally signals better cardiovascular resilience. Both are now measurable with consumer wearables like Garmin and Apple Watch, though laboratory-grade accuracy still requires chest-strap ECG monitoring.

Grip Strength and Muscle Mass

Grip strength is a surprisingly robust mortality predictor. A large 2015 Lancet study across 17 countries found that each 5 kg decrease in grip strength was associated with a 17% higher risk of all-cause mortality. Skeletal muscle mass, measured via DEXA scan, predicts insulin sensitivity, falls risk, and survival in aging adults. Our post on muscle mass and longevity statistics breaks down the data in detail.

Biological Age and Epigenetic Biomarkers

Chronological age tells you how long you’ve been alive. Biological age — estimated through epigenetic clocks and related tools — tells you how fast your cells are aging. These two numbers can diverge significantly.

Epigenetic Clocks (DNA Methylation Testing)

Epigenetic clocks measure methylation patterns at specific sites across your genome to estimate biological age. The Horvath clock (2013), PhenoAge clock, and GrimAge clock are the most studied. GrimAge in particular has been shown to predict time-to-death independently of chronological age in multiple population cohorts. As of 2026, consumer tests from companies like TruDiagnostic and Elysium Health make these accessible, typically for $200-$500 per test.

Honest caveat: test-to-test variability remains a real limitation. A single biological age reading reflects your state at that moment and carries measurement error. Serial testing every 6-12 months, tracking trends rather than single values, is the smarter approach. Our deep-dive on what epigenetic clocks actually measure covers the methodology and current limitations.

Emerging Signal: Circulating MicroRNAs

A 2026 study published in NPJ Aging (PMID 41690959) analyzed microRNA profiles in plasma-derived extracellular vesicles across the human lifespan. The researchers found that while extracellular vesicle size and concentration remained largely unchanged with age, older individuals showed distinct microRNA signatures. This is preliminary evidence, from a single cohort study, and circulating microRNA tests are not yet clinically available. But they represent a compelling next generation of aging biomarkers.

Inflammatory and Immune Biomarkers

Chronic low-grade inflammation — increasingly called “inflammaging” in the research literature — is a central mechanism linking diet, gut health, and accelerated biological aging. A 2026 review in Nutrients (PMID 41599842) noted that evidence from Blue Zone populations and Mediterranean diet studies associates specific nutritional interventions with up to a 23% lower all-cause mortality, with analyses suggesting that part of this association may be mediated through reduced inflammaging. That’s a human review — meaningful, though it reflects observational data rather than controlled trials.

High-Sensitivity CRP (hsCRP)

High-sensitivity C-reactive protein is the most practical inflammation marker for routine monitoring. Optimal hsCRP for longevity is below 0.5 mg/L. Values above 3.0 mg/L signal significant systemic inflammation and warrant investigation. Elevated hsCRP predicts cardiovascular events, cancer risk, and all-cause mortality across multiple large prospective studies.

IL-6 and TNF-alpha

Interleukin-6 and tumor necrosis factor-alpha are pro-inflammatory cytokines that rise with age and adiposity. These are less commonly ordered in routine care, but many longevity-focused clinicians include them. IL-6 in particular is a strong predictor of frailty and mortality in older adults, according to research from the NIH National Institute on Aging.

Homocysteine

Elevated homocysteine (above 10-12 umol/L) is associated with cardiovascular disease, cognitive decline, and increased oxidative stress. It’s inexpensive to test and often correctable with B-vitamin supplementation (B6, B12, folate). Many standard panels skip it — worth requesting specifically.

Organ-Specific Longevity Biomarkers

Beyond metabolic and inflammatory markers, specific organ systems have their own most informative signals.

Liver: ALT and GGT

Alanine aminotransferase (ALT) above 25 U/L in women and above 35 U/L in men can signal early non-alcoholic fatty liver disease (NAFLD), now the most common liver condition globally. Gamma-glutamyl transferase (GGT) is sensitive to alcohol exposure, oxidative stress, and metabolic dysfunction. Both are included in a comprehensive metabolic panel.

Kidney: eGFR and Creatinine

Estimated glomerular filtration rate (eGFR) measures how efficiently your kidneys filter waste. Decline in eGFR below 60 mL/min/1.73m² signals chronic kidney disease. Importantly, eGFR typically declines about 1 mL/min/year after age 40, so trending over time matters more than any single value.

Thyroid: TSH and Free T3

Thyroid function affects metabolism, cognition, cardiovascular health, and energy. TSH alone is the standard screen, but free T3 gives a more direct picture of active thyroid hormone. Many longevity physicians also include reverse T3 and thyroid antibodies for a complete picture.

The Complete Longevity Biomarker Tracking Table

How to Build Your Biomarker Tracking Protocol

Tracking everything at once is expensive and can create anxiety over noise. A practical approach is to tier your testing by cost, evidence quality, and actionability.

Tier 1 — Test annually, covered by most insurance: fasting glucose, HbA1c, lipid panel, hsCRP, ALT, eGFR, TSH, complete blood count. Request ApoB specifically — it’s often not included by default.

Tier 2 — Test annually, often out-of-pocket ($100-$300 total): fasting insulin (for HOMA-IR calculation), homocysteine, free T3, IL-6, Lp(a) (lipoprotein-a, a genetic cardiovascular risk factor that doesn’t respond to lifestyle changes and you need to know if you have it).

Tier 3 — Test every 12-24 months, higher cost: epigenetic age via DNA methylation, DEXA scan for body composition and bone density, VO2 max test (lab or field test), coronary artery calcium (CAC) score for cardiovascular baseline.

The goal isn’t perfect numbers. The goal is trend data — watching markers improve or worsen over time in response to your interventions. If you’re doing the work outlined in our longevity exercise guide and our biological age testing overview, biomarkers are the feedback loop that tells you whether it’s working.

One note on skin: a 2026 review in Dermatology and Therapy (PMID 41926038) confirmed that skin aging markers reflect intrinsic biological decline and extrinsic exposome factors including UV radiation, stress, and sleep disruption. Skin isn’t a clinical biomarker yet, but it is a visible integration of whole-body aging — and it responds meaningfully to the same interventions that improve your blood markers.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only recommend products we genuinely believe in. Learn more.

Frequently Asked Questions

What are the most important longevity biomarkers to track?

VO2 max, ApoB, fasting insulin, HbA1c, and hsCRP form the core panel for longevity-focused adults. Together, these five markers cover cardiovascular fitness, metabolic health, and systemic inflammation — the three domains most strongly linked to premature death. Epigenetic age testing adds a useful biological age layer, though it’s more expensive and carries more measurement variability.

How often should I get my longevity biomarkers tested?

Most metabolic and inflammatory blood markers should be tested annually. Functional markers like VO2 max and grip strength can be assessed every 6-12 months, especially if you’re actively working to improve them. Epigenetic age tests are best done every 12-24 months — testing more frequently than that makes it hard to separate real biological change from measurement noise.

Is ApoB better than LDL for predicting heart disease?

Yes, for most people. ApoB counts the actual number of atherogenic lipoprotein particles in your blood, while LDL-cholesterol measures the cholesterol mass carried by those particles. People with high triglycerides or low HDL can have normal LDL but high ApoB — meaning standard LDL alone would miss a significant risk. Most longevity-focused cardiologists now treat ApoB as the primary lipid target.

Can epigenetic clock tests tell me my real biological age?

They can estimate it — with meaningful caveats. Epigenetic clocks like GrimAge and PhenoAge have been validated against mortality risk in population studies, and a biological age younger than your chronological age is a good sign. But single-test accuracy is limited by individual measurement variability. Use them as trend indicators across multiple tests, not as a definitive verdict from one reading.

What biomarker best predicts how long I’ll live?

VO2 max has the strongest and most replicated human evidence for predicting longevity. The 2018 Cleveland Clinic study of 122,007 patients found that cardiorespiratory fitness was a stronger predictor of all-cause mortality than hypertension, diabetes, or smoking history. No blood biomarker, including epigenetic clocks, has matched that effect size in human research as of 2026.

Are there longevity biomarkers I can track at home?

Yes. Resting heart rate and heart rate variability (HRV) can be tracked daily with a consumer wearable. Grip strength requires only a hand dynamometer (under $30). Blood pressure is measurable at home with a cuff. Continuous glucose monitors (CGMs) are now available without a prescription in many countries and provide rich metabolic data that a once-yearly HbA1c can’t match.

Sources

• Mandsager K, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. 2018. Cleveland Clinic cohort, n=122,007.
• Leong DP, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet. 2015.
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013.
• Lu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019.
• Wang et al. MicroRNA profiles in plasma-derived extracellular vesicles across the human lifespan. NPJ Aging. 2026. PMID 41690959.
• Kouvari M, et al. A Conceptual Digital Health Framework for Longevity Optimization: Inflammation-Centered Approach Integrating Microbiome and Lifestyle Data. Nutrients. 2026. PMID 41599842.
• Integrative Dermatology for Longevity: The Synergy of Topical and Internal Approaches. Dermatology and Therapy. 2026. PMID 41926038.
• NIH National Institute on Aging. Biology of Aging Research. nia.nih.gov.
• Attia P. Outlive: The Science and Art of Longevity. Harmony Books, 2023.